Contineum Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (CTNM)

57 filings reported holding CTNM - Contineum Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share as of Q3 2024.
Contineum Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (CTNM) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13.6M shares of 21.9M outstanding shares and own 62.21% of the company stock.
Largest 10 shareholders include JOHNSON & JOHNSON (1.98M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1.72M shares), PERCEPTIVE ADVISORS LLC (1.52M shares), FRANKLIN RESOURCES INC (1.45M shares), Versant Venture Management, LLC (918K shares), SECTORAL ASSET MANAGEMENT INC (801K shares), FMR LLC (697K shares), HHLR ADVISORS, LTD. (669K shares), Samsara BioCapital, LLC (589K shares), and VANGUARD GROUP INC (461K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.